Industry-funded study of the week: Unilever

A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia.  Blom AM, et al.  European Journal of Nutrition.  2019;58(4):1615–1624.

Purpose: “to investigate the triglyceride (TG) and LDL-cholesterol (LDL-C) lowering effects of a spread [i.e., margarine] with added plant sterols (PS) and fish oil as compared to a placebo spread.”

Conclusions: “Four-week consumption of the intervention spread led to significant and clinically relevant decreases in serum TG, LDL-C and other blood lipid concentrations.”

Funder: The study was funded by Unilever BCS Research and Development Vlaardingen, the Netherlands.

Conflicts of interest: of the authors, four are employed by Unilever.

Comment: Unilever makes margarines with plant sterols and fish oils.  You might buy them if they control blood lipid risk factors for heart disease.  This is in-house company research aimed at proving the benefits of a Unilever product, which is what so many other companies do.

But Unilever was one of the few Big Food companies that sponsored basic research (and maybe it still does?).  As I describe in my book, Unsavory Truth, Unilever was the sponsor of the basic research that demonstrated the harmful effects of trans-fat on disease risk.